Literature DB >> 2146954

Atrial natriuretic factor mRNA and binding sites in the adrenal gland.

D J Nunez1, A P Davenport, M J Brown.   

Abstract

The factor inhibiting aldosterone secretion produced by the adrenal medulla may be atrial natriuretic factor (ANF), since the latter abolishes aldosterone release in response to a number of secretagogues, including angiotensin II and K+. In this study we have shown that cells in the adrenal medulla contain ANF mRNA and therefore have the potential to synthesize this peptide. The presence of binding sites for ANF predominantly in the adrenal zona glomerulosa suggests that, if ANF is synthesized in the medulla and transferred to the cortex, it may affect mineralocorticoid status.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2146954      PMCID: PMC1149591          DOI: 10.1042/bj2710555

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  40 in total

1.  Atrial natriuretic polypeptide inhibits cortisol secretion as well as aldosterone secretion in vitro from human adrenal tissue.

Authors:  M Naruse; K Obana; K Naruse; H Yamaguchi; H Demura; T Inagami; K Shizume
Journal:  J Clin Endocrinol Metab       Date:  1987-01       Impact factor: 5.958

Review 2.  Atrial natriuretic peptide: what is the excitement all about?

Authors:  J V Anderson; S R Bloom
Journal:  J Endocrinol       Date:  1986-07       Impact factor: 4.286

3.  In vitro autoradiographic localization of ANP receptors in rat kidney and adrenal gland.

Authors:  S Y Chai; P M Sexton; A M Allen; R Figdor; F A Mendelsohn
Journal:  Am J Physiol       Date:  1986-04

4.  Atrial natriuretic factor regulation of cyclic GMP levels and steroidogenesis in isolated fasciculata cells of rat adrenal cortex.

Authors:  N Jaiswal; A K Paul; R K Jaiswal; R K Sharma
Journal:  FEBS Lett       Date:  1986-04-07       Impact factor: 4.124

5.  George E. Brown memorial lecture. Role of atrial peptides in body fluid homeostasis.

Authors:  B J Ballermann; B M Brenner
Journal:  Circ Res       Date:  1986-05       Impact factor: 17.367

6.  Structure and analysis of the bovine atrial natriuretic peptide precursor gene.

Authors:  G P Vlasuk; J Miller; G H Bencen; J A Lewicki
Journal:  Biochem Biophys Res Commun       Date:  1986-04-14       Impact factor: 3.575

7.  Atrial natriuretic peptide inhibits the effect of endogenous angiotensin II on plasma aldosterone in conscious sodium-depleted rats.

Authors:  L Chartier; E L Schiffrin
Journal:  Clin Sci (Lond)       Date:  1987-01       Impact factor: 6.124

8.  Immunoreactive atrial natriuretic polypeptides in the adrenal medulla and sympathetic ganglia.

Authors:  S Inagaki; Y Kubota; S Kito; K Kangawa; H Matsuo
Journal:  Regul Pept       Date:  1986-10

9.  Prolonged administration of human atrial natriuretic peptide in healthy men. Reduced aldosteronotropic effect of angiotensin II.

Authors:  H Vierhapper; P Nowotny; W Waldhäusl
Journal:  Hypertension       Date:  1986-11       Impact factor: 10.190

10.  Localization of specific binding sites for atrial natriuretic factor in peripheral tissues of the guinea pig, rat, and human.

Authors:  C R Mantyh; L Kruger; N C Brecha; P W Mantyh
Journal:  Hypertension       Date:  1986-08       Impact factor: 10.190

View more
  2 in total

1.  Differential regulation of natriuretic peptide receptor messenger RNAs during the development of cardiac hypertrophy in the rat.

Authors:  L A Brown; D J Nunez; M R Wilkins
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

2.  Localization and coexistence of atrial natriuretic peptide (ANP) and neuropeptide Y (NPY) in vertebrate adrenal chromaffin cells immunoreactive to TH, DBH and PNMT.

Authors:  M Wolfensberger; W G Forssmann; M Reinecke
Journal:  Cell Tissue Res       Date:  1995-05       Impact factor: 5.249

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.